Sponsor:
University of Alberta
Code:
NCT06695221
Conditions
Systemic Inflammatory Response
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Eligibility Criteria
Sex: All
Age: 24 - 70
Healthy Volunteers: Not accepted
Interventions
Traditional Kefir
Milk (placebo)
Brief summary:
Conditions
Systemic Inflammatory Response
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Study ID
NCT06695221
Start date
Mar 24, 2026
Status verified date
May, 2026
Completion date
Dec, 2027
Anticipated
Primary completion date
Dec, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 24 - 70
Healthy Volunteers: Not accepted
Enrollment
156 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Participants living with T2D
experimental: Participants with higher risk of T2D
Interventions
Traditional Kefir
Milk (placebo)
Primary outcome measure
Central contacts
Locations
University of Alberta
Recruiting
Edmonton, Alberta, Canada, T6G 2E1
Contacts
Principal Investigator:
Benjamin Willing, PhD
Sponsor
University of Alberta
Last update posted
May 8, 2026
Last verified
May, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Alberta on 2026-05-08.